As a result of the anti-inflammatory effects of Metrnl, via downregulation of IL-6 and TNF-α, it may be hypothesized that Metrnl not only plays crucial roles in the regulation of insulin pathways, it also improves CAD and T2DM pathogenesis via the down-regulation of inflammation. The gene discussed is TNF; the disease is coronary artery disorder.